BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Uterine cancer AND LDH AND Diagnosis
24 results:

  • 1. Primary lymphoma of the female genital tract masquerading as gynecological malignancy.
    Shi S; Li W; Ni G; Ding J; Liu Y; Wu H; Zhang Z; Ding Z
    BMC Womens Health; 2024 Apr; 24(1):247. PubMed ID: 38637800
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. CEP55 predicts the poor prognosis and promotes tumorigenesis in endometrial cancer by regulating the Foxo1 signaling.
    Zhang X; Xu Q; Li E; Shi T; Chen H
    Mol Cell Biochem; 2023 Jul; 478(7):1561-1571. PubMed ID: 36434144
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. KIFC1 promotes aerobic glycolysis in endometrial cancer cells by regulating the c-myc pathway.
    Zhou K; Lin J; Dai M; He Y; Xu J; Lin Q
    J Bioenerg Biomembr; 2021 Dec; 53(6):703-713. PubMed ID: 34729671
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Evaluation of Biomarkers in Myoma Patients: A Prospective Study Investigating the Role of ldh, CA 125, and IGF-1 after Uterus-Preserving Surgical Therapy.
    Jacob M; Richter R; Sehouli J; David M
    Gynecol Obstet Invest; 2021; 86(1-2):100-107. PubMed ID: 33582665
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Preoperative clinical characteristics scoring system for differentiating uterine leiomyosarcoma from fibroid.
    Zhang G; Yu X; Zhu L; Fan Q; Shi H; Lang J
    BMC Cancer; 2020 Jun; 20(1):514. PubMed ID: 32493236
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Circulating Protein Biomarkers to Differentiate uterine Sarcomas from Leiomyomas.
    Glorie N; Baert T; VAN DEN Bosch T; Coosemans AN
    Anticancer Res; 2019 Aug; 39(8):3981-3989. PubMed ID: 31366479
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. A more accurate method to interpret lactate dehydrogenase (ldh) isoenzymes' results in patients with uterine masses.
    Di Cello A; Borelli M; Marra ML; Franzon M; D'Alessandro P; Di Carlo C; Venturella R; Zullo F
    Eur J Obstet Gynecol Reprod Biol; 2019 May; 236():143-147. PubMed ID: 30925450
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Increased ldh5/ldh1 ratio in preoperative diagnosis of uterine sarcoma with inconclusive MRI and ldh total activity but suggestive CT scan: a case report.
    Mollo A; Raffone A; Travaglino A; Di Cello A; Saccone G; Zullo F; De Placido G
    BMC Womens Health; 2018 Oct; 18(1):169. PubMed ID: 30340636
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Diagnostic value of combination serum assay of lactate dehydrogenase, D-dimer, and C-reactive protein for uterine leiomyosarcoma.
    Nishigaya Y; Kobayashi Y; Matsuzawa Y; Hasegawa K; Fukasawa I; Watanabe Y; Tokunaga H; Yaegashi N; Iwashita M
    J Obstet Gynaecol Res; 2019 Jan; 45(1):189-194. PubMed ID: 30152048
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. [Analysis of proliferative lesions of haematopoietic and lymphoid tissue in the female productive tract].
    Chen DB; Zhang H; Zhang YH; Wang Y; Song QJ; Yang SM; Cui H; Zhao Y; Fang XZ; Shen DH
    Zhonghua Fu Chan Ke Za Zhi; 2018 Apr; 53(4):263-269. PubMed ID: 29747272
    [No Abstract]    [Full Text] [Related]  

  • 11. Efficacy of PET/CT to exclude leiomyoma in patients with lesions suspicious for uterine sarcoma on MRI.
    Kusunoki S; Terao Y; Ujihira T; Fujino K; Kaneda H; Kimura M; Ota T; Takeda S
    Taiwan J Obstet Gynecol; 2017 Aug; 56(4):508-513. PubMed ID: 28805609
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Use of 18F-fluorodeoxyglucose positron emission tomography for diagnosis of uterine sarcomas.
    Nagamatsu A; Umesaki N; Li L; Tanaka T
    Oncol Rep; 2010 Apr; 23(4):1069-76. PubMed ID: 20204293
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. A case of extremely chemoresistant pure pleomorphic rhabdomyosarcoma of the uterus associated with a high serum ldh level.
    Yeasmin S; Nakayama K; Oride A; Ishibashi M; Ishikawa N; Katagiri A; Iida K; Nakayama N; Miyazaki K
    Eur J Gynaecol Oncol; 2008; 29(5):518-22. PubMed ID: 19051826
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. De novo uterine sarcoma with good response to neo-adjuvant chemotherapy.
    Numa F; Umayahara K; Ogata H; Nawata S; Sakaguchi Y; Emoto T; Kawasaki K; Hirakawa H; Sase M; Oga A; Kato H
    Int J Gynecol Cancer; 2003; 13(3):364-7. PubMed ID: 12801270
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Usefulness of Gd-DTPA contrast-enhanced dynamic MRI and serum determination of ldh and its isozymes in the differential diagnosis of leiomyosarcoma from degenerated leiomyoma of the uterus.
    Goto A; Takeuchi S; Sugimura K; Maruo T
    Int J Gynecol Cancer; 2002; 12(4):354-61. PubMed ID: 12144683
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. A case of primary non-Hodgkin's lymphoma of the uterine cervix treated by combination chemotherapy (THP-COP).
    Nasu K; Yoshimatsu J; Urata K; Miyakawa I
    J Obstet Gynaecol Res; 1998 Apr; 24(2):157-60. PubMed ID: 9631606
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Peritoneal fluid lactate dehydrogenase in ovarian cancer.
    Schneider D; Halperin R; Langer R; Bukovsky I; Herman A
    Gynecol Oncol; 1997 Sep; 66(3):399-404. PubMed ID: 9299252
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. [Role of polychemoembolization in the treatment of primary and secondary tumors of the liver].
    Recchia F; Passalacqua G; De Filippis S; Filauri P; Lippe P; Rea S; Fingerhut A; Frati L
    Clin Ter; 1995 Feb; 146(2):117-22. PubMed ID: 7789072
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. [The values of urine cysteine protein activity in the diagnosis of ovarian cancer].
    Xi MR; Peng ZL; Cao ZY
    Zhonghua Fu Chan Ke Za Zhi; 1994 Feb; 29(2):85-7, 123. PubMed ID: 8033632
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. [diagnosis of ovarian tumor by measuring tumor markers].
    Fukatsu T; Nakashima N; Takeuchi J
    Rinsho Byori; 1992 Feb; 40(2):133-8. PubMed ID: 1583785
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.